J. Rheumatol. 2020 Feb 01
Feasibility and face validity of outcome measures for use in future studies of Polymyalgia Rheumatica (PMR): An OMERACT Study.
Yates M, Owen CE, Muller S, Graham K, Neill L, Twohig H, Boers M, Pujades-Rodriguez M, Goodman S, Cheah J, Dejaco C, Mukhtyar C, Nielsen BD, Robson J, Simon LS, Shea B, Mackie SL, Hill CL
The aim of this study was to survey participants with PMR to evaluate the face validity, acceptability and domain match of proposed candidate outcome ...
Read More
Source: PubMed
Joint Bone Spine 2020 Jan 30
Muscle involvement on 18F-FDG PET-CT in polymyalgia rheumatica. A controlled study.
Wendling D, Sondag M, Giraud N, Chouk M, Boulahdour H, Prati C, Verhoeven F
18F-fluoro deoxy glucose PET scanner (18F-FDG-PET-CT) has shown its interest in the diagnosis of polymyalgia rheumatica (PMR) and makes possible to ev ...
Read More
Source: PubMed
Indian J Nucl Med
Semiquantitative Interpretation Criteria for Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography in Large-Vessel Vasculitis: Pattern Recognition and Correlation with Polymyalgia Rheumatica.
Malik D, Verma R, Gupta V, Belho ES, Drolia B, Seniaray N, Mahajan H
Fluorine-18-fluorodeoxyglucose (18F-FDG)-positron emission tomography/computed tomography (PET/CT) is emerging as a useful imaging modality in suspect ...
Read More
Source: PubMed
Eur. J. Intern. Med. 2020 Jan 08
Usefulness of serum amyloid a protein dosage for monitoring patients receiving tocilizumab.
Michaud M, Catros F, Gaches F
Read More
Source: PubMed
Eur J Rheumatol 2019 Dec 16
Relapse of polymyalgia rheumatica following adjuvanted influenza vaccine: A case-based review.
Bassendine MF, Bridge SH
Polymyalgia rheumatica (PMR) is the most common inflammatory rheumatological condition affecting individuals aged >50 years. There have been rare repo ...
Read More
Source: PubMed
